Company Filing History:
Years Active: 2005
Title: Frank Dahlke - Innovator in Autoimmune Disease Treatment
Introduction
Frank Dahlke is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. His innovative approach has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Frank Dahlke holds a patent for the "Use of biogenic estriol diester prodrugs for the treatment of autoimmune diseases." This invention focuses on the use of esters of estriol, such as estriol 3,17-dipropionate and estriol 3,17-dihexanoate, for treating autoimmune diseases like multiple sclerosis (MS). His work in this area has the potential to improve the quality of life for many patients suffering from these conditions.
Career Highlights
Throughout his career, Frank has been associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His role there has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Frank Dahlke has worked alongside notable colleagues, including Walter Elger and Sybille Beier. Their combined expertise has fostered an environment of innovation and progress in the treatment of autoimmune diseases.
Conclusion
Frank Dahlke's contributions to the field of medicine through his patent and collaborations highlight his commitment to advancing healthcare solutions. His work continues to inspire future innovations in the treatment of autoimmune diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.